Introduction
============

As the most common cancer originating from the nasopharynx ([@b1-ol-0-0-4940]), nasopharyngeal carcinoma (NPC) can be caused by viral influence, heredity and environmental factors ([@b2-ol-0-0-4940]). The viral influence is correlated with infection by Epstein-Barr virus (EBV), which is a B-lymphotropic herpes virus possessing growth-transforming properties ([@b3-ol-0-0-4940]). It has been reported that 95% of Americans are exposed to this virus in their thirties ([@b4-ol-0-0-4940]). In 2010, NPC led to 65,000 mortalities globally ([@b5-ol-0-0-4940]). Thus, there is an urgent requirement to study the mechanisms of EBV-associated NPC.

Recently, a number of studies have been performed to investigate the mechanisms of EBV-associated NPC. For example, as an early EBV antigen ([@b6-ol-0-0-4940]), BamH1-A Reading Frame-1 may be associated with the pathogenesis of NPC, such as the malignant transformation of human NPC epithelial cells ([@b7-ol-0-0-4940],[@b8-ol-0-0-4940]). Aberrant hypermethylation of Ras association domain family 1 isoform A and the high viral load of EBV DNA may play an important role in NPC pathogenesis, thus, they may function as promising diagnostic markers for NPC ([@b9-ol-0-0-4940],[@b10-ol-0-0-4940]). Serological results have shown that specifically expressed *BRLF1* may be used in the diagnosis of NPC ([@b11-ol-0-0-4940]). Via the activation of *Ets-1*, *c-Met* can be induced by latent membrane protein-1 (*LMP-1*) and enhance the highly metastatic potential of NPC ([@b12-ol-0-0-4940]). By providing epitopes recognized by cytotoxic T-cells, EVB-encoded *LMP2A* may be a potential target and may be used in the immunotherapy of NPC ([@b13-ol-0-0-4940]).

In 2006, Sengupta *et al* ([@b14-ol-0-0-4940]) analyzed the expression of all latent EBV genes between NPC samples and normal healthy nasopharyngeal epithelium samples, and obtained a panel of differentially-expressed genes (DEGs). Using the same data by Sengupta *et al* ([@b14-ol-0-0-4940]), the present study aimed to further screen the DEGs and predict their underlying function by functional and pathway enrichment analyses. Furthermore, protein-protein interaction network (PPI) networks were constructed and modules of PPI network were searched to investigate the interaction associations between these DEGs.

Materials and methods
=====================

### Microarray data

The expression profile of the GSE12452 dataset deposited by Sengupta *et al* ([@b14-ol-0-0-4940]) was downloaded from Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo/>), which was based on the platform of the GPL570 \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array. GSE12452 consisted of a collection of 31 NPC samples and 10 normal healthy nasopharyngeal tissue samples. These samples were collected from Taiwanese patients who provided informed consent. After the tissues were resected and immediately flash frozen, samples were finally stored in liquid nitrogen.

### DEG screening

Once GSE12452 had been downloaded, the microarray data was read using Affy package ([www.bioconductor.org](www.bioconductor.org)) ([@b15-ol-0-0-4940]) and Refseq annotation files, and then it was normalized by the Robust MultiArray Averaging method ([@b16-ol-0-0-4940]). The linear models for microarray data package (<http://www.bioconductor.org>) ([@b17-ol-0-0-4940]) in R was used to identify the DEGs between NPC samples and normal healthy nasopharyngeal tissue samples. The adjusted P-value of \<0.01 and \|logfold-change (FC)\|\>1 were used as the cut-off criteria.

### Functional and pathway enrichment analysis

Gene Ontology (GO) terms can describe three wild-type gene products, including molecular function, biological process and subcellular location ([@b18-ol-0-0-4940]). The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database is used for the systematic analysis of gene functions, which can connect genomic information with functional information ([@b19-ol-0-0-4940]). The Database for Annotation, Visualization, and Integrated Discovery (DAVID) is a program that can integrate functional genomic annotations with intuitive summaries ([@b20-ol-0-0-4940]). Using DAVID software, GO and KEGG pathway enrichment analyses were performed for DEGs between NPC samples and normal healthy nasopharyngeal tissue samples. A P-value of \<0.05 was used as the cut-off criterion.

### PPI network and module construction

Interaction associations of the proteins encoded by the DEGs were searched by Search Tool for the Retrieval of Interacting Genes/Proteins online software (<http://string-db.org/>) ([@b21-ol-0-0-4940]), and then PPI networks were visualized by Cytoscape software (<http://www.cytoscape.org>) ([@b22-ol-0-0-4940]). The proteins in the PPI network were termed nodes and the degree of a node correlated with the number of its interactions. Using network statistics, a connectivity degree analysis was conducted for each node in the PPI network. ClusterONE (<http://www.paccanarolab.org/clusterone/>) ([@b23-ol-0-0-4940]) in Cytoscape was used to screen modules of the PPI network. A P-value of \<0.01 was used as the cut-off criterion.

Results
=======

### DEG analysis

Compared with normal healthy nasopharyngeal tissue samples, a total of 951 DEGs were screened from the NPC samples, including 376 upregulated and 575 downregulated genes. There were more downregulated genes than upregulated genes.

### Functional and pathway enrichment analysis

The enriched GO functions for upregulated genes were divided into 28 clusters. Functions in cluster 1 were associated with the cell cycle, such as the M phase (P=5.27×10^−30^) and the cell cycle process (P=3.34×10^−29^). Functions in cluster 2 were associated with cytoskeleton organization, such as the microtubule-based process (P=1.09×10^−11^) and microtubule cytoskeleton organization (P=7.27×10^−11^). Functions in cluster 3 were implicated in the regulation of the cell cycle, such as the regulation of the mitotic cell cycle (P=6.43×10^−9^) and the regulation of cell cycle process (P=7.79×10^−6^). Functions in cluster 4 were involved in DNA metabolism, such as the DNA metabolic process (P=1.80×10^−12^) and the response to a DNA damage stimulus (P=5.83×10^−8^) ([Table I](#tI-ol-0-0-4940){ref-type="table"}).

The enriched GO functions for downregulated genes were divided into 9 clusters. For instance, functions in cluster 1 were associated with cell differentiation, such as epithelial cell differentiation (P=4.04×10^−7^) and keratinocyte differentiation (P=3.48×10^−3^). Functions in cluster 2 were involved in hormone metabolism, such as the regulation of hormone levels (P=5.75×10^−4^) and the cellular hormone metabolic process (P=4.25×10^−2^). Functions in cluster 3 were associated with the inflammatory response, such as the acute inflammatory response (P=1.55×10^−3^) and the response to wounding (P=3.86×10^−3^). Functions in cluster 4 were implicated in the immune response, such as the humoral immune response (P=1.89×10^−3^) and the humoral immune response mediated by circulating immunoglobulin (P=3.12×10^−2^) ([Table I](#tI-ol-0-0-4940){ref-type="table"}).

The enriched KEGG pathways for upregulated genes are also listed in [Table I](#tI-ol-0-0-4940){ref-type="table"}, including the cell cycle (P=3.32×10^−11^), extracellular matrix-receptor interaction (P=1.75×10^−7^) and DNA replication (P=2.74×10^−6^). Additionally, pathway enrichment analysis was conducted for downregulated genes. As shown in [Table I](#tI-ol-0-0-4940){ref-type="table"}, pathways such as those for the metabolism of xenobiotics by cytochrome P450 (P=1.82×10^−4^), drug metabolism (P=2.25×10^−4^) and retinol metabolism (P=4.45×10^−3^) were enriched ([Table I](#tI-ol-0-0-4940){ref-type="table"}).

### PPI network and module analysis

The PPI network for upregulated genes had 279 nodes and 5,690 interactions. In particular, upregulated mitotic arrest deficient 2-like 1 (*MA D2L1*; degree=133), replication factor C4 (degree=130), proliferating cell nuclear antigen (*PCNA*; degree=125), cyclin-dependent kinase 1 (degree=124) and cyclin B1 (*CCNB1*; degree=115) exhibited higher degrees in the PPI network. Modules 1 ([Fig. 1](#f1-ol-0-0-4940){ref-type="fig"}) and 2 ([Fig. 2](#f2-ol-0-0-4940){ref-type="fig"}) were obtained from the PPI network of upregulated genes. Module 1 had 144 nodes and 5,091 interactions. Module 2 had 23 nodes and 133 interactions. The cell cycle was an enriched pathway for the DEGs in modules 1 and 2.

The PPI network for downregulated genes had 260 nodes and 517 interactions. Importantly, downregulated glutathione S-transferase α1 (*GSTA1*; degree=19), *GSTA3* (degree=19), dynein, light chain, roadblock-type 2 (degree=17), calmodulin 1 (degree=16), member A1 of aldehyde dehydrogenase 1 (*ALDH1A1*; degree=15) and sperm-associated antigen 6 (degree=15) had higher degrees in the PPI network. Modules 3 ([Fig. 3](#f3-ol-0-0-4940){ref-type="fig"}) and 4 ([Fig. 4](#f4-ol-0-0-4940){ref-type="fig"}) were obtained from the PPI network of downregulated genes. Module 3 had 13 nodes and 48 interactions. The enriched pathway for DEGs in module 3 included the mitogen-activated protein kinase signaling pathway. Module 4 had 11 nodes, such as mucin 1 (*MUC1*), and 43 interactions. O-glycan biosynthesis was an enriched pathway for DEGs in module 4.

Discussion
==========

In the present study, 951 DEGs were screened in the NPC samples compared with normal healthy nasopharyngeal tissue samples. Function enrichment indicated that the upregulated genes were mainly associated with the cell cycle, cytoskeleton organization and DNA metabolism. The downregulated genes were associated with cell differentiation, hormone metabolism, the inflammatory response and the immune response. Meanwhile, upregulated *MAD2L1* (degree=133), *PCNA* (degree=125) and *CCNB1* (degree=115), and downregulated *ALDH1A1* (degree=15) exhibited higher degrees of interaction in the PPI network.

Via the induction of mitotic arrest, *MAD2* can cause chemosensitization to cisplatin in NPC cells and activate the apoptosis pathway ([@b24-ol-0-0-4940]). The aberrantly reduced expression of *MAD2* can lead to a defective mitotic checkpoint and promote chromosomal instability in the disease ([@b25-ol-0-0-4940]). Sensitization to vincristine induced by *MAD2* is associated with *Raf*/*Bcl-2* phosphorylation and mitotic arrest in NPC cells ([@b26-ol-0-0-4940]). The M-phase events of *MAD2* and *CCNB1/CDC2* activation are essential to the paclitaxel-induced apoptosis of human NPC cells ([@b27-ol-0-0-4940]). Thus, the expression levels of *MAD2L1* and *CCNB1* may be associated with NPC. It has been reported that upregulated *BCL-2* and a high *PCNA* labeling index may be implicated in local recurrence in NPC patients receiving the primary treatment of radiation therapy ([@b28-ol-0-0-4940]). Through inhibiting the expression of *PCNA*, a PCNA-small interfering RNA compound can effectively interfere with NPC cells and may be used in the gene therapy of NPC ([@b29-ol-0-0-4940]). These data indicate that *PCNA* may also play a role in NPC.

The expression of *ALDH1* in the invasive front links, which is associated with tumor aggressiveness and epithelial-mesenchymal transition characteristics, may serve as a promising predictive factor in NPC ([@b30-ol-0-0-4940],[@b31-ol-0-0-4940]). Budding cells characterized by a high level of *ALDH1* may have invasive and metastatic properties, therefore, the degree of expression can be a useful prognostic marker in NPC patients ([@b32-ol-0-0-4940]). It has been reported that the overexpression of *ALDH1A1* in NPC is associated with enhanced invasiveness ([@b33-ol-0-0-4940]). These data indicate that *ALDH1A1* may have a close correlation with NPC. *MUC1*, a mucinous glycoprotein required for the detachment and release of tumor cells, combined with other invasiveness and angiogenic factors may function in a complex sequential process that ends in the metastasis of EBV-infected NPC cells ([@b34-ol-0-0-4940]). This may indicate that the expression level of *MUC1* is associated with EBV-associated NPC.

In conclusion, in the present study, an integrated bioinformatics analysis of genes that may be involved in EBV-associated NPC was performed. A total of 951 DEGs were screened in the NPC samples compared with the normal healthy nasopharyngeal tissue samples. Certain DEGs, such as *MAD2L1*, *CCNB1*, *PCNA*, *ALDH1A1* and *MUC1*, may have a correlation with NPC. However, future studies are required to advance the understanding of their mechanisms of action in NPC.
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###### 

Enriched GO functions and KEGG pathways for the upregulated and downregulated genes^[a](#tfn1-ol-0-0-4940){ref-type="table-fn"}^.

  A, Enriched GO functions for the upregulated genes                                                                                                                                                                                  
  ----------------------------------------------------------------------- ------------ ------- ---------------------------------------------------------------- ---------- ---------------------------------------------------------- --------------
  BP                                                                      GO:0000279           M phase                                                          53         *DBF4, KNTC1, TTK*                                         5.27×10^−30^
  BP                                                                      GO:0022402           Cell cycle process                                               66         *DBF4, KNTC1, TTK*                                         3.34×10^−29^
  BP                                                                      GO:0007017           Microtubule-based process                                        28         *KIF23, CAV1, KIF4A*                                       1.09×10^−11^
  BP                                                                      GO:0000226           Microtubule cytoskeleton organization                            21         *KIF23, CAV1, KIF11*                                       7.27×10^−11^
  BP                                                                      GO:0007346           Regulation of mitotic cell cycle                                 19         *CDC7, DLGAP5, TIPIN*                                      6.43×10^−9^
  BP                                                                      GO:0010564           Regulation of cell cycle process                                 13         *CDC7, DLGAP5, TIPIN*                                      7.79×10^−6^
  BP                                                                      GO:0006259           DNA metabolic process                                            41         *UNG, DBF4, TIPIN*                                         1.80×10^−12^
  BP                                                                      GO:0006974           Response to DNA damage stimulus                                  28         *UNG, TIPIN, PRKDC*                                        5.83×10^−8^
                                                                                                                                                                                                                                      
  B, Enriched GO functions for the downregulated genes                                                                                                                                                                                
                                                                                                                                                                                                                                      
  Category                                                                Term                 Description                                                      Gene no.   Gene symbol^[b](#tfn2-ol-0-0-4940){ref-type="table-fn"}^   P-value
                                                                                                                                                                                                                                      
  BP                                                                      GO:0030855           Epithelial cell differentiation                                  16         *ELF3, FOXA1, ANXA1*                                       4.04×10^−7^
  BP                                                                      GO:0030216           Keratinocyte differentiation                                       7        *SPRR1A, PPL, CNFN*                                        3.48×10^−3^
  BP                                                                      GO:0010817           Regulation of hormone levels                                     12         *FAM3B, FOXA1, DUOX2*                                      5.75×10^−4^
  BP                                                                      GO:0034754           Cellular hormone metabolic process                                 5        *DHRS9, UGT1A6, UGT1A10*                                   4.25×10^−2^
  BP                                                                      GO:0002526           Acute inflammatory response                                        9        *F3, CLU, SAA4*                                            1.55×10^−3^
  BP                                                                      GO:0009611           Response to wounding                                             23         *S100A9, ANXA1, PRDX5*                                     3.86×10^−3^
  BP                                                                      GO:0006959           Humoral immune response                                            8        *CFB, FOXJ1, CLU*                                          1.89×10^−3^
  BP                                                                      GO:0002455           Humoral immune response mediated by circulating immunoglobulin     4        *C7, CD55, CR2*                                            3.12×10^−2^
                                                                                                                                                                                                                                      
  C, Enriched KEGG pathways for the upregulated and downregulated genes                                                                                                                                                               
                                                                                                                                                                                                                                      
  Regulation                                                              Category     Term    Description                                                      Gene no.   Gene symbol^[b](#tfn2-ol-0-0-4940){ref-type="table-fn"}^   P-value
                                                                                                                                                                                                                                      
  Up                                                                      KEGG         04110   Cell cycle                                                       21         *COL4A2, COL4A1, COL3A1*                                   3.32×10^−11^
                                                                          KEGG         04512   ECM-receptor interaction                                         14         *COL4A2, COL4A1, COL3A1*                                   1.75×10^−7^
                                                                          KEGG         03030   DNA replication                                                    9        *RFC5, DNA2, RFC3*                                         2.74×10^−6^
                                                                          KEGG         03430   Mismatch repair                                                    7        *RFC5, EXO1, MSH6*                                         1.92×10^−5^
                                                                          KEGG         04115   p53 signaling pathway                                              9        *CCNE2, CCNB1, CDK1*                                       3.32×10^−4^
  Down                                                                    KEGG         00980   Metabolism of xenobiotics by cytochrome P450                       8        *GSTA1, GSTA3, ADH1C*                                      1.82×10^−4^
                                                                          KEGG         00982   Drug metabolism                                                    8        *GSTA3, ADH1C, ADH7*                                       2.25×10^−4^
                                                                          KEGG         00830   Retinol metabolism                                                 6        *UGT1A1, UGT1A7, ALDH1A1*                                  4.45×10^−3^
                                                                          KEGG         00590   Arachidonic acid metabolism                                        5        *AKR1C3, GGT6, ALOX15*                                     2.61×10^−2^
                                                                          KEGG         04640   Hematopoietic cell lineage                                         6        *MS4A1, CD1C, CD1D*                                        2.96×10^−2^

The enriched GO terms listed in the table are the functions for the top four clusters with the highest enriched score.

Only the most relevant genes in each category are listed. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; BP, biological process. KNTC, kinetochore associated; KIF, kinesin family; CAV, caveolin; CDK, cyclin-dependent kinase; CDC, cell division cycle; DLGAP, discs large homolog associated protein; TIPIN timeless-interacting protein; UNG, uracil DNA glycosylase; PRKDC, protein kinase, DNA-activated, catalytic polypeptide; SPRR, small proline rich protein; PPL, periplakin; CNFN, cornifelin; DHRS, dehydrogenase/reductase (SDR family); UGT, UDP glucuronosyltransferase; ELF3, E74-like ETS transcription factor 3; FOX, forkhead box; ANX, annexin; FAM, family with sequence similarity; DUOX, dual oxidase; F3, coagulation factor III, tissue factor; CLU, clusterin; SAA4, serum amyloid A4, constitutive; S100A9, S100 calcium binding protein A9; PRDX, peroxiredoxin; CFB, complement factor B; C7, complement component 7; CD, cluster of differentiation; CR2, complement component 3d receptor 2; COL, collagen; RFC, replication factor C; DNA2, DNA replication helicase/nuclease 2; EXO, exonuclease; MSH, mutS homolog; CCN, cyclin; GSTA, glutathione S-transferase alpha; ADH, alcohol dehydrogenase; AKR, aldo-keto reductase; GGT, gamma-glutamyltransferase; ALOX15, arachidonate 15-lipoxygenase; MS4A1, membrane spanning 4-domains A1.
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